Literature DB >> 20309653

Cascade impactor (CI) mensuration--an assessment of the accuracy and precision of commercially available optical measurement systems.

Frank Chambers1, Aziz Ali, Jolyon Mitchell, Christopher Shelton, Steve Nichols.   

Abstract

Multi-stage cascade impactors (CIs) are the preferred measurement technique for characterizing the aerodynamic particle size distribution of an inhalable aerosol. Stage mensuration is the recommended pharmacopeial method for monitoring CI "fitness for purpose" within a GxP environment. The Impactor Sub-Team of the European Pharmaceutical Aerosol Group has undertaken an inter-laboratory study to assess both the precision and accuracy of a range of makes and models of instruments currently used for optical inspection of impactor stages. Measurement of two Andersen 8-stage 'non-viable' cascade impactor "reference" stages that were representative of jet sizes for this instrument type (stages 2 and 7) confirmed that all instruments evaluated were capable of reproducible jet measurement, with the overall capability being within the current pharmacopeial stage specifications for both stages. In the assessment of absolute accuracy, small, but consistent differences (ca. 0.6% of the certified value) observed between 'dots' and 'spots' of a calibrated chromium-plated reticule were observed, most likely the result of treatment of partially lit pixels along the circumference of this calibration standard. Measurements of three certified ring gauges, the smallest having a nominal diameter of 1.0 mm, were consistent with the observation where treatment of partially illuminated pixels at the periphery of the projected image can result in undersizing. However, the bias was less than 1% of the certified diameter. The optical inspection instruments evaluated are fully capable of confirming cascade impactor suitability in accordance with pharmacopeial practice.

Mesh:

Substances:

Year:  2010        PMID: 20309653      PMCID: PMC2850462          DOI: 10.1208/s12249-010-9405-0

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  3 in total

1.  Considerations for the development and practice of cascade impaction testing, including a mass balance failure investigation tree.

Authors:  Dave Christopher; Paul Curry; Bill Doub; Kenneth Furnkranz; Martin Lavery; Karl Lin; Svetlana Lyapustina; Jolyon Mitchell; Brian Rogers; Helen Strickland; Terrence Tougas; Yi Tsong; Bruce Wyka
Journal:  J Aerosol Med       Date:  2003

Review 2.  Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.

Authors:  Jolyon P Mitchell; Mark W Nagel
Journal:  J Aerosol Med       Date:  2003

3.  Relationship of stage mensuration data to the performance of new and used cascade impactors.

Authors:  Daryl L Roberts; Francisco J Romay
Journal:  J Aerosol Med       Date:  2005
  3 in total
  2 in total

Review 1.  Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs).

Authors:  Jolyon Mitchell; Richard Bauer; Svetlana Lyapustina; Terrence Tougas; Volker Glaab
Journal:  AAPS PharmSciTech       Date:  2011-07-22       Impact factor: 3.246

2.  Good Cascade Impactor Practice (GCIP) and considerations for "in-use" specifications.

Authors:  S C Nichols; J P Mitchell; C M Shelton; D L Roberts
Journal:  AAPS PharmSciTech       Date:  2013-01-24       Impact factor: 3.246

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.